Milestone Pharmaceuticals Inc (NASDAQ:MIST)
| 2.97 Delayed Data As of 3:59pm ET |  -0.13 / -4.19%Today’s Change | 2.68 Today|||52-Week Range 9.73 | -25.00% Year-to-Date |
Latest MIST News | Press Releases
No recent news for Milestone Pharmaceuticals Inc.
Today’s Trading
| Previous close | 3.10 |
| Today’s open | 2.99 |
| Day’s range | 2.97 - 3.02 |
| Volume | 962 |
| Average volume (3 months) | 112,615 |
| Market cap | $103.5M |
Data as of 3:59pm ET, 10/02/2023
Growth & Valuation
| Earnings growth (last year) | -34.26% |
| Earnings growth (this year) | -9.57% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -66.67% |
| P/E ratio | NM |
| Price/Sales | 33.62 |
| Price/Book | 1.60 |
Competitors
| ---- | ||
| MNOVMediciNova Inc | -0.07 | -3.59% |
| ABEOAbeona Therapeutics ... | -0.15 | -3.56% |
| INOInovio Pharmaceutica... | -0.00 | -0.08% |
Data as of 3:59pm ET, 10/02/2023
Financials
| Next reporting date | November 16, 2023 |
| EPS forecast (this quarter) | -$0.39 |
| Annual revenue (last year) | $5.0M |
| Annual profit (last year) | -$58.4M |
| Net profit margin | -1,167.76% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Montréal, Quã©bec |
Forecasts
